These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 35211404
1. Transsphenoidal Surgery of Corticotroph Adenomas With Cavernous Sinus Invasion: Results in a Series of 86 Consecutive Patients. Dai C, Feng M, Lu L, Sun B, Fan Y, Bao X, Yao Y, Deng K, Wang R, Kang J. Front Oncol; 2022; 12():810234. PubMed ID: 35211404 [Abstract] [Full Text] [Related]
2. Clinicoradiological Parameters and Biochemical and Molecular Alterations Predicting Remission and Recurrence After Surgical Treatment of Corticotroph Adenomas-Cushing Disease. Sadhwani N, Bora SK, Deepa S, Katiyar V, Raheja A, Garg A, Suri V, Tandon N, Sharma MC, Khadgawat R, Suri A. World Neurosurg; 2024 Jul; 187():e937-e948. PubMed ID: 38734175 [Abstract] [Full Text] [Related]
3. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G. Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366 [Abstract] [Full Text] [Related]
4. [Performance of Knosp grade for cavernous sinus invasion of Cushing's disease]. Xu XY, Wang RZ. Zhonghua Yi Xue Za Zhi; 2019 Jan 29; 99(5):388-390. PubMed ID: 30772983 [Abstract] [Full Text] [Related]
5. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis. Briceno V, Zaidi HA, Doucette JA, Onomichi KB, Alreshidi A, Mekary RA, Smith TR. Neurol Res; 2017 May 29; 39(5):387-398. PubMed ID: 28301972 [Abstract] [Full Text] [Related]
6. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. Juraschka K, Khan OH, Godoy BL, Monsalves E, Kilian A, Krischek B, Ghare A, Vescan A, Gentili F, Zadeh G. J Neurosurg; 2014 Jul 29; 121(1):75-83. PubMed ID: 24785323 [Abstract] [Full Text] [Related]
7. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N. J Neurosurg; 2014 Dec 29; 121(6):1462-73. PubMed ID: 25237847 [Abstract] [Full Text] [Related]
8. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas. Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S, Anand VK, Schwartz TH. J Neurosurg; 2017 Aug 29; 127(2):397-408. PubMed ID: 27791524 [Abstract] [Full Text] [Related]
9. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. Nishioka H, Fukuhara N, Horiguchi K, Yamada S. J Neurosurg; 2014 Sep 29; 121(3):505-10. PubMed ID: 25014437 [Abstract] [Full Text] [Related]
10. Predictors of Immediate Remission after Surgery in Cushing's Disease Patients: A Large Retrospective Study from a Single Center. Dai C, Fan Y, Liu X, Bao X, Yao Y, Wang R, Feng M. Neuroendocrinology; 2021 Sep 29; 111(11):1141-1150. PubMed ID: 32512562 [Abstract] [Full Text] [Related]
11. Surgical outcome of transsphenoidal surgery in Cushing's disease: a case series of 1106 patients from a single center over 30 years. Dai C, Feng M, Sun B, Bao X, Yao Y, Deng K, Ren Z, Zhao B, Lu L, Wang R, Kang J. Endocrine; 2022 Jan 29; 75(1):219-227. PubMed ID: 34415482 [Abstract] [Full Text] [Related]
12. Outcomes of Transsphenoidal Surgery in Cushing Disease Patients with Negative Pituitary Magnetic Resonance Imaging Findings: A Single-Center Experience. Dai C, Liang S, Liu X, Fan Y, Bao X, Yao Y, Deng K, Lu L, Wang R, Feng M. Endocr Pract; 2020 Nov 29; 26(11):1320-1330. PubMed ID: 33471663 [Abstract] [Full Text] [Related]
14. Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients. Guo X, Zhang R, Zhang D, Wang Z, Gao L, Yao Y, Deng K, Bao X, Feng M, Xu Z, Yang Y, Lian W, Wang R, Ma W, Xing B. J Neurosurg; 2022 Sep 01; 137(3):618-628. PubMed ID: 35171834 [Abstract] [Full Text] [Related]
15. Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results. Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G, Gentili F. J Neurosurg; 2020 Nov 01; 133(5):1360-1370. PubMed ID: 31604330 [Abstract] [Full Text] [Related]
19. Endoscopic transsphenoidal resection of pituitary adenomas invading the cavernous sinus. Kalinin PL, Sharipov OI, Pronin IN, Kutin MA, Fomichev DV, Kadashev BA, Shkarubo AN, Alekseev SN, Astaf'eva LI, Tropinskaya OF, Dobrovol'skiy GF, Shul'ts EI, Andreev DN, Voronina IA, Kurnosov AB. Zh Vopr Neirokhir Im N N Burdenko; 2016 Nov 01; 80(4):63-74. PubMed ID: 27500775 [Abstract] [Full Text] [Related]
20. Endoscopic Endonasal Resection of the Medial Wall of the Cavernous Sinus and Its Impact on Outcomes of Pituitary Surgery: A Systematic Review and Meta-Analysis. de Macêdo Filho LJM, Diógenes AVG, Barreto EG, Pahwa B, Samson SL, Chaichana K, Quinones-Hinojosa A, Almeida JP. Brain Sci; 2022 Oct 06; 12(10):. PubMed ID: 36291288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]